4.5 Article

Targeted Next-Generation Sequencing Identifies Molecular and Genetic Events in Dedifferentiated Chondrosarcoma

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Myxoid glioneuronal tumor, PDGFRA p.K385-mutant: clinical, radiologic, and histopathologic features

Calixto-Hope G. Lucas et al.

BRAIN PATHOLOGY (2020)

Review Chemistry, Medicinal

Development of Novel Therapeutics Targeting Isocitrate Dehydrogenase Mutations in Cancer

Horrick Sharma

CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)

Article Biochemistry & Molecular Biology

Presence of TERT Promoter Mutations is a Secondary Event and Associates with Elongated Telomere Length in Myxoid Liposarcomas

Monica S. Ventura Ferreira et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Oncology

Dedifferentiated chondrosarcoma: A survival analysis of 159 cases from the SEER database (2001-2011)

Patrick K. Strotman et al.

JOURNAL OF SURGICAL ONCOLOGY (2017)

Review Oncology

Understanding TERT Promoter Mutations: A Common Path to Immortality

Robert J. A. Bell et al.

MOLECULAR CANCER RESEARCH (2016)

Article Anatomy & Morphology

Rational Manual and Automated Scoring Thresholds for the Immunohistochemical Detection of TP53 Missense Mutations in Human Breast Carcinomas

Nicholas J. Taylor et al.

APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)

Article Oncology

TERT promoter mutations are rare in bone and soft tissue sarcomas of Japanese patients

Tsuyoshi Saito et al.

MOLECULAR AND CLINICAL ONCOLOGY (2016)

Article Biochemistry & Molecular Biology

Unique mutation portraits and frequent COL2A1 gene alteration in chondrosarcoma

Yasushi Totoki et al.

GENOME RESEARCH (2014)

Article Oncology

TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities

Christian Koelsche et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2014)

Article Genetics & Heredity

Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma

Patrick S. Tarpey et al.

NATURE GENETICS (2013)

Article Oncology

Genetic characterization of mesenchymal, clear cell, and dedifferentiated chondrosarcoma

Danielle Meijer et al.

GENES CHROMOSOMES & CANCER (2012)

Article Oncology

Dedifferentiated chondrosarcoma: Prognostic factors and outcome from a European group

Robert J. Grimer et al.

EUROPEAN JOURNAL OF CANCER (2007)

Article Orthopedics

Dedifferentiated chondrosarcoma: The role of chemotherapy with updated outcomes

ID Dickey et al.

JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2004)

Article Pathology

Mutation of p53 with loss of heterozygosity in the osteosarcomatous component of a dedifferentiated chondrosarcoma

HJ Grote et al.

VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)